Prestige Consumer Healthcare (PBH) Capital Leases (2019 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Capital Leases of $18.7 million for Q4 2025, up 357.49% year-over-year from $4.1 million in Q4 2024, and down 3.45% quarter-over-quarter from $19.3 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Capital Leases (2019 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Capital Leases history runs 7 years deep, the most recent figure standing at $18.7 million for Q4 2025.
- In Q4 2025, Capital Leases rose 357.49% year-over-year to $18.7 million; the TTM figure through Dec 2025 stood at $18.7 million (up 357.49% YoY), while the FY2025 annual figure was $20.6 million, up 11890.7% from the prior year.
- Capital Leases for Q4 2025 stood at $18.7 million, down from $19.3 million in the prior quarter.
- The five-year high for Capital Leases was $20.6 million in Q1 2025, with the low at $126000.0 in Q3 2024.
- The 5-year median for Capital Leases is $3.9 million (2022), against an average of $6.2 million.
- The sharpest annual moves came in 2023 and 2025: Capital Leases slumped 92.95% in 2023, then jumped 15232.54% in 2025.
- Prestige Consumer Healthcare's Capital Leases stood at $4.8 million in 2021, then tumbled by 50.61% to $2.4 million in 2022, then slumped by 91.82% to $195000.0 in 2023, then surged by 1990.77% to $4.1 million in 2024, then jumped by 357.49% to $18.7 million in 2025.
- Business Quant data shows PBH's Capital Leases at $18.7 million in Q4 2025, $19.3 million in Q3 2025, and $20.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.97 Mn |
| Dec 31, 2025 | 18.65 Mn |
| Sep 30, 2025 | 19.32 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Mar 31, 2025 | 20.62 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 172,000.00 |
| Dec 31, 2023 | 195,000.00 |
| Sep 30, 2023 | 218,000.00 |
| Jun 30, 2023 | 945,000.00 |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 3.09 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 4.50 Mn |
| Dec 31, 2021 | 4.83 Mn |
| Sep 30, 2021 | 5.49 Mn |
| Jun 30, 2021 | 6.16 Mn |